P53突变与卵巢癌患者对铂类化疗的耐药性有关

{"title":"P53突变与卵巢癌患者对铂类化疗的耐药性有关","authors":"D. Katsaros","doi":"10.1054/EBON.2002.0037","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100515,"journal":{"name":"Evidence-based Oncology","volume":"69 1","pages":"141-142"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"p53 mutations are associated with resistance to platinum-based chemotherapy in ovarian cancer\",\"authors\":\"D. Katsaros\",\"doi\":\"10.1054/EBON.2002.0037\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100515,\"journal\":{\"name\":\"Evidence-based Oncology\",\"volume\":\"69 1\",\"pages\":\"141-142\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Evidence-based Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1054/EBON.2002.0037\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Evidence-based Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1054/EBON.2002.0037","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}